Commission awards project of cancer research with €1.5 million

The European Commission awards its 50th European Industrial Doctorate (EID) research grant. The €1.5 million grant is for research into new antibodies that will destroy a tumour's blood vessels and eradicate the tumour. The so-called VAMPIRE project ('Vascular Antibody-Mediated Pharmaceutically Induced tumour Resection') is led by the University of Birmingham in the UK and SomantiX, a Dutch biotech company based in Utrecht. The research is supported by associated European universities, companies and research centres including Swiss science and technology university ETH Zurich and the charity Cancer Research UK. The EID scheme is targeted at projects which bring together business and academic partners in two countries.

See more information here: http://europa.eu/rapid/press-release_IP-13-784_en.htm